Back to Trades
NEWHALL CHARLES W III
DirectorCIK 0001005544
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Across 8 filings between 2025–2026, NEWHALL CHARLES W III, Director, has disclosed $5.0M in transactions — all concentrated in SUPERNUS PHARMACEUTICALS, INC. (SUPN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.5M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Nov 4 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Other | $2.9M |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Grant | $0 |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Award | $249.8K |
| Nov 24 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Exercise | $389.4K |
| Oct 10 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $1.3M |
| Aug 29 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $161.5K |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $45.0K |
| Aug 26 | SUPN SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Sell | $63.5K |
8 filings